Preclinical and clinical study of siddha drugs Raja elathy choornam(internal) and Nathaichoori ennai(external) in the treatment of shoulder pain (Kumbavatham) with and without varmam.
Phase 3
- Conditions
- Health Condition 1: null- Kumbavatham (peri arthritis shoulder)
- Registration Number
- CTRI/2017/05/008593
- Lead Sponsor
- Ayothidoss pandithar hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1) Pain and stiffness of shoulder region
2) Exacerbation of pain on movement
3) Restricted movements of shoulder joint
4) With or without pain radiating to upper arm
5) Patient willing to undergo radiological investigation and give blood samples for laboratory investigations
6) Patient willing to sign the informed consent stating that he/she will conciously stict to the treatment but can opt out of the trial of his/her own concious discretion
Exclusion Criteria
H/O Diabetes mellitus
H/O Cardiac disease
H/O septic arthritis
H/O Gonococcal arthritis
H/O Pregnancy and lactation
H/O Malignant hypertention
H/O Any fracture and dislocation of shoulder joint
H/O Cervical spondylosis
H/O Any other chronic illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcome is aimed at reducing pain and stiffness in the shoulder joint <br/ ><br>Increasing the range of movements of shoulder joint measured by SPADITimepoint: 48 days
- Secondary Outcome Measures
Name Time Method Effect of varmam in kumbavatham patients in addition to internal drugs evaluated by SPADI score <br/ ><br>To study siddha pricipals like envagai thervu, Neerkuri, Neikuri <br/ ><br>Safety assessment of the trial drugs by doing toxicology studies in animal models.Timepoint: 48 days